Amalgamated Bank Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Amalgamated Bank raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the third quarter, Holdings Channel reports. The firm owned 188,028 shares of the healthcare conglomerate’s stock after buying an additional 1,300 shares during the quarter. UnitedHealth Group makes up approximately 0.9% of Amalgamated Bank’s portfolio, making the stock its 13th biggest position. Amalgamated Bank’s holdings in UnitedHealth Group were worth $109,936,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group in the 3rd quarter worth $27,000. Macroview Investment Management LLC raised its position in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares during the period. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group during the second quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates lifted its stake in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.7 %

UNH stock opened at $557.77 on Tuesday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The firm’s 50-day simple moving average is $581.37 and its 200 day simple moving average is $542.90. The stock has a market cap of $515.06 billion, a PE ratio of 36.34, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.56 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.51%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analysts Set New Price Targets

A number of research firms recently issued reports on UNH. TD Cowen boosted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. UBS Group decreased their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Argus boosted their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.